Immediate Response With Adalimumab and Its Impact on Quality of Life and Other Comorbidity Factors in Patients With Moderate to Severe Plaque Psoriasis
NCT01265823
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
150
Enrollment
INDUSTRY
Sponsor class
Conditions
Psoriasis
Interventions
BIOLOGICAL:
Adalimumab
Sponsor
AbbVie (prior sponsor, Abbott)